Go Deep
CellSeed Inc.
CellSeed Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,002 | -6.5 | 4.20 | 0.15 | 114.41 |
| Oct 2026 | 18,802 | -6.9 | 4.40 | 0.15 | 119.63 |
CellSeed Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 7,164,000.0 | 13,656,000.0 | 18,418,000.0 | 28,262,000.0 |
| Net Profit | -338,384,000.0 | -272,227,000.0 | -254,590,000.0 | -198,349,000.0 |
| EPS | — | -7.2 | — | — |
CellSeed Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 83,678,000.0 | 193,277,000.0 | 190,134,000.0 | 126,427,000.0 | — |
| Net Profit | -1,104,101,000.0 | -859,840,000.0 | -846,534,000.0 | -759,680,000.0 | — |
| EPS | -31.8 | — | -29.4 | -36.3 | -53.1 |
CellSeed Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 1,655,840,000.0 | 2,433,084,000.0 | 2,465,768,000.0 | 1,543,920,000.0 | — |
| Total Liabilities | 387,460,000.0 | 269,881,000.0 | 301,047,000.0 | 365,582,000.0 | — |
| Total Equity | 1,268,380,000.0 | 2,163,203,000.0 | 2,164,721,000.0 | 1,178,338,000.0 | — |
Owes vs Owns
CellSeed Inc. owed ¥0.15 for every ¥1 it owned in Jun 2026, down from ¥0.24 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.15× | 0.23× | 0.11× | 0.12× | 0.24× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
CellSeed Inc. Assets & Liabilities Breakdown (JPY millions)
What it owns — Dec 2025
Cash & short-term investments 79.7%Inventory 4.8%Long-term investments 1.3%Other assets 13.9%
How it's funded — Dec 2025
Short-term debt 1.7%Long-term debt 6.4%Other liabilities 15.4%Shareholders' equity 76.6%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1,318.9 | 2,134.3 | 2,163.3 | 1,072.2 |
| Receivables | 6.8 | 37.1 | 51.9 | 25.8 |
| Inventory | 78.8 | 46.0 | 46.2 | 56.2 |
| Fixed assets (tangible) | 0.0 | 0.0 | 0.0 | 98.3 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 21.4 | 20.5 | 0.0 | 119.5 |
| Other assets | 229.9 | 195.1 | 204.4 | 172.0 |
| Liabilities & equity | ||||
| Short-term debt | 27.5 | 10.8 | 7.5 | 7.5 |
| Long-term debt | 105.4 | 132.9 | 143.8 | 151.2 |
| Payables | 0.4 | 6.2 | 3.8 | 0.4 |
| Other liabilities | 254.2 | 119.9 | 146.0 | 206.4 |
| Shareholders' equity | 1,268.4 | 2,163.2 | 2,164.7 | 1,178.3 |
| Net tangible assets | 1,268.4 | 2,163.2 | 2,164.7 | 1,178.3 |
CellSeed Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -988,976,000.0 | -866,104,000.0 | -779,435,000.0 | -718,006,000.0 | — |
| Investing Activities | -26,717,000.0 | -18,367,000.0 | 56,315,000.0 | 61,728,000.0 | — |
| Financing Activities | 200,304,000.0 | 855,479,000.0 | 1,814,201,000.0 | 881,814,000.0 | — |